reSee.it - Related Video Feed

Video Saved From X

reSee.it Video Transcript AI Summary
Speaker 0 describes capabilities to disrupt an individual from the cellular level to the system level, targeting a specific individual with little attribution or trace, and leaving prior to attribution. The aim includes disrupting individuals and the social fabric, up to influencing through various levels. Speaker 1 claims that targeting demonstrators can make them suicidally depressed, so they no longer demonstrate, with one pulse frequency causing people to be too upset to act, preferring sleep or bed. He says we are in a new cold war and that countries are developing this technology, with microwave transmitters going up everywhere because someone could use them for other effects; the system is up and running. Speaker 2 notes MIT was awarded around 2005-2006 a half a million dollars for acoustic heterodyning, enabling sending a signal from two points into an individual so they literally hear a voice in their head that nobody around them hears. Speaker 1 adds that stimulating the cochlea with a resonant frequency is easy, and voices can be heard physically, not imagined, with any conversation and for any person; it can be a soft angelic voice, a god, or something that scares you like a devil. Speaker 2 states that DARPA led contracts in 2011-2012 to the University of California for electronic telepathy, monitoring brain activity at a distance to determine thoughts, and developing complex signals to send into another’s brain to transmit a message; the technology described is where the field stands today. Speaker 0 emphasizes the brain as the twenty-first century battlespace, with neurocognitive science weaponized in military, personal, and professional lives; the weaponization is valid, valuable, and already an operational play; the brain is the current and future battle space. New aspects include in-close use, targeting individuals with possible direct attribution or covert engagement with non-attribution, and a formal definition of a weapon involving directed energy affecting physiology peripherally and brain health, with embassy incidents in Havana and possibly China cited. Transcranial neuromodulation is discussed as a method to modulate brain networks and implant brain-machine interfaces, including DARPA’s N3 program (non-invasive neurosurgical neuromodulation) led by Doctor Al Mundy, aiming to place minimal electrodes to read and write into real-time brain function remotely, affecting attitudes, beliefs, thoughts, emotions, and activities. Speaker 1 explains an infrared device linked to a pencil-thin microwave source to target a specific gland or brain region, eye, or heart to cause targeted suffering. Speaker 3 states intelligence communities are gaining too much influence over governments, moving toward a Stasi-like state, warning that agencies threaten fundamental human rights and calling for verification and oversight to keep agencies in line, implying that governments will experiment on individuals if pursued. Speaker 1 asserts that over the last forty years, governments have lied to protect industry and profits, and that the industry and supporting government parts will cause more civilian deaths and suffering than all terrorist groups, possibly more than World War II, with a claim that this is genocide and that those responsible are untouchable and outside the law, tied to IGNAP, WHO, and national health agencies as the same people. Speaker 3 expresses disappointment in the American public for not being more irritated, contrasting with Germans who remember totalitarian history (Stasi, Gestapo, SS), noting sensitivity in Germany. Dr. John Hall is mentioned in this context. Speaker 4 references a memorandum from the president about whether current legislation protects individuals and whether ongoing experimentation exists, noting loopholes in informed consent; horror experiments like Willowbrook, MK Ultra cited, funded by DoD and intelligence agencies, questioning IRB oversight and informed consent; a rise in complaints about electromagnetic weapons, including microwave auditory effects, silent sound spectrum, EEG cloning, remote lab-to-home transmission; testimony that 1,500 victims report identical electromagnetic exposure complaints. Speaker 5 introduces Katherine Nestor from Pennsylvania, who recounts non-consensual testing, COINTELPRO-like stalking, remote neural monitoring, and electromagnetic torture causing psychological and physical damage; she urges immediate action and congressional hearings, referencing Dr. Amy Gutmann and new work for the Commission for Human Subject Protection. Speaker 3 introduces Connie Marshall from Louisville, Kentucky, a formal mayoral candidate and eight-year victim of directed energy assaults, listing symptoms: body overheating/cold, seizures, heart pain, earaches, itching behind eyes, swelling, involuntary movements, exhaustion, rapid heart rate, hair loss, mind paralysis, hypnotic states, drone/satellite tracking, controlled dreams, sleep deprivation, voice-to-skull, extreme muscle spasms/cramps, eye pupil circles, continuous monitoring, destruction of devices, and being watched 24/7.

Video Saved From X

reSee.it Video Transcript AI Summary
A magnetic wand that controls the brain was tested on the speaker. Psychiatrist Mark George made the speaker's thumb twitch by zapping a specific area of the brain. The speaker also experienced their toe being affected by the wand.

Video Saved From X

reSee.it Video Transcript AI Summary
People were initially opposed to implanting brain chips in rats to control their movement. However, after 9/11, funding for DARPA increased significantly, leading to the development of biohybrids. For example, scientists created a moth with a brain chip implanted in its larva, allowing them to control its flight. Four years ago, I interviewed these scientists about their work. They also studied limb regeneration in salamanders, believing that humans could one day regenerate limbs too. They explained that humans, like salamanders, started as single cells and have the potential for regeneration. The biohybrid moths can be controlled by electrical stimulation, directing their movements.

Video Saved From X

reSee.it Video Transcript AI Summary
Neuralink chip is not yet widely used, but the first patient, a quadriplegic, will soon be able to control their computer and phone with it. Another person who had a brain chip implanted can now walk and talk. The regulatory process for these chips is rigorous. The next version of the chip will allow users to control devices through their thoughts, like telepathy. There are plans to develop a chip that can restore vision to those who are blind. It may even enable people to see in multiple wavelengths, including ultraviolet, infrared, and radar. This technology could be called "Blindsight."

Video Saved From X

reSee.it Video Transcript AI Summary
Speaker 0 explains that when you move your arm, your brain sends a signal to your muscles, and there is a nerve near the skin (the ulnar nerve) that innervates three fingers. The idea presented is to stimulate that nerve so that copying your brain signal sent to your hand makes your hand move when your brain tells it to move. In other words, this could cause someone to “take away your free will” and become your agent, removing control over the hand. The demonstration proceeds with locating the ulnar nerve and connecting it to a human-to-human interface. Sam is asked to squeeze his hand to provide a signal. The setup is described as feeling strange at first, similar to losing free will and having someone else act as your agent, so Sam is asked to relax his hand. Miguel is invited to participate. Sam squeezes again, and the device is connected so the signal can be simulated in the hand. Miguel is asked if he is ready; he says he is. The device is turned on, and Miguel’s hand begins to move in response to the brain signal. Sam is asked to squeeze again, and the response is repeated with a small, controlled movement. The presenter then demonstrates that both hands can be controlled: the brain is currently controlling both Miguel’s arm and Sam’s arm. Miguel is asked to relax his hand, and the question is posed: what happens if the presenter takes over control of Miguel’s hand? When Miguel relaxes, nothing happens because the brain must initiate the movement. Miguel then performs the action again, confirming the effect. The session concludes with gratitude to the participants. The presenter notes that this is happening worldwide in electrophysiology and proclaims a forthcoming “neuro revolution.”

Video Saved From X

reSee.it Video Transcript AI Summary
BrainBridge performs head and face transplants using advanced robotic systems for faster recoveries. The procedure involves attaching a patient's head to a healthy donor body, preserving consciousness and memories. Surgical robots work simultaneously on both bodies, maintaining blood flow and reattaching nerves and tissues. A face and scalp transplant follows, enhancing aesthetics and functionality. Immunosuppressive drugs prevent rejection, and postoperative care includes coma, stabilization, and rehabilitation. BrainBridge's AI algorithms adapt in real time, improving surgical techniques and recovery plans. Collaboration with experts ensures comprehensive care, from immune compatibility to postoperative rehabilitation. BrainBridge aims to give new life to patients through head transplants.

Video Saved From X

reSee.it Video Transcript AI Summary
Neuralink introduces the PRIME study, a clinical trial for a device that can transform the lives of people with paralysis. The device, a small implant in the brain, allows users to connect with loved ones, browse the web, and play games using their thoughts. No physical movement is required. The study is open to those with quadriplegia or ALS. By participating, individuals can redefine human capability and shape the future of interaction and independence. A dedicated team will support participants throughout the journey. To learn more and apply, visit the Neuralink website.

Video Saved From X

reSee.it Video Transcript AI Summary
Our body uses electrical signals in nerves to communicate with organs. By implanting microchips on peripheral nerves, we can read and correct messages to organs, potentially treating chronic diseases. These chips are specific, local, and only intervene when needed, ensuring patient compliance.

The Dhru Purohit Show

A New Way to Treat PTSD, Concussions, and Traumatic Brain Injuries
Guests: Erik Won
reSee.it Podcast Summary
In this episode of the Broken Brain Podcast, host Dhru Purohit interviews Dr. Erik Wong, president of Wave Neuroscience, about magnetic resonance therapy, a groundbreaking technology for treating mental health issues such as PTSD, traumatic brain injury, and suicide prevention. Dr. Wong shares his journey from aspiring priest to Navy flight surgeon, highlighting the profound impact of his military experiences, including a tragic helicopter accident that shaped his career path and commitment to helping veterans. Dr. Wong discusses the challenges veterans face during their transition to civilian life, including loss of camaraderie and purpose, which contribute to high suicide rates among veterans. He emphasizes the importance of understanding these struggles and the need for effective support systems. Current PTSD treatments primarily involve cognitive behavioral therapy and medication, but Dr. Wong advocates for exploring alternative therapies, including magnetic resonance therapy. This therapy involves a three-step process, starting with a quantitative EEG to assess brain function, followed by transcranial magnetic stimulation to stimulate underactive brain areas. Dr. Wong notes the potential for this technology to optimize brain performance and improve quality of life, not just for veterans but for a broader population, including those with autism and cognitive decline. He expresses optimism for future clinical trials and the potential to expand treatment options, emphasizing the importance of sleep and holistic approaches to brain health.

Huberman Lab

Protect & Improve Your Hearing & Brain Health | Dr. Konstantina Stankovic
Guests: Konstantina Stankovic
reSee.it Podcast Summary
Mounting evidence connects hearing loss with dementia, and this episode with Dr. Konstantina Stankovic explains why protecting hearing matters for brain health as well as communication. Hearing loss affects about 1.5 billion people, with half a billion disabled, and the World Health Organization projects another billion by 2050. Subtle deficits can begin in childhood, yet many go untreated. The inner ear is astonishingly tiny: the cochlea, about the size of Lincoln’s upper face on a penny, holds two fluids, endolymph and perilymph. Sound travels down the ear canal, vibrates the eardrum, and moves the three bones—hammer, anvil, stirrup—setting fluids in motion. Hair cells convert this mechanical energy into electrical signals that travel via the auditory nerve to the brain. Stankovic highlights the cochlea’s place–frequency map: high frequencies are encoded at the base and low frequencies at the apex. Outer hair cells move at audio frequencies, enabling exquisite sensitivity, while the inner hair cells transmit signals to the brain. The ear’s precision lets us hear speech, music, and subtle changes, but it also makes the system vulnerable to noise, aging, and drugs. There are two broad loss types: conductive, which hampers sound conduction, and sensory neural, which originates in the inner ear. Tinnitus, a phantom sound, and hyperacusis, painful sensitivity to sound, illustrate how brain circuits can amplify or misinterpret signals after reduced input. Damage to synapses between hair cells and auditory neurons may underlie hidden hearing loss, even when standard hearing tests appear normal. Clinically, amplification via hearing aids helps the conductive or some sensory losses, while cochlear implants offer access to sound for profound deafness and can ease tinnitus distress by restoring peripheral input. Beyond protection, the episode links hearing to cognition and emotion. The cocktail party effect shows the brain’s ability to focus on a single speaker amid noise, while untreated hearing loss correlates with social isolation and cognitive decline, contributing to economic and health burdens. Tests that assess speech in noise may better identify dementia risk than quiet-threshold exams. The discussion covers patient management, including the option of cognitive behavioral therapy for tinnitus and, when appropriate, cochlear implants. It also touches ethics: some Deaf communities debate cochlear implants as a choice rather than a cure. Finally, research into hair‑cell regeneration in birds offers a hopeful path for restoring hearing in mammals.

The Peter Attia Drive Podcast

363 ‒ A new frontier in neurosurgery: brain-computer interfaces, new hope for brain diseases, & more
Guests: Edward Chang
reSee.it Podcast Summary
Neurosurgery still feels like peering into a black box, yet the frontier is shifting as brain computer interfaces promise new ways to diagnose, treat, and restore function. The episode centers on GBMs, strokes, and other brain diseases, highlighting awake surgery and real-time brain mapping as a way to maximize tumor removal while preserving language and movement. The brain itself has no pain receptors, so a patient can be awake under local scalp anesthesia and light sedation while surgeons work. The guest recalls that seeing the cortex pulse and measuring neurons sparked her lifelong fascination with brain function. Historical milestones anchor the field, from Harvey Cushing, the father of modern neurosurgery, to Wilder Penfield and awake epilepsy surgery. The discussion traces cranial openings to the present, where laser probes, focused ultrasound, and endovascular techniques now shrink invasiveness and extend life. Vascular work that once required large craniotomies is increasingly done through catheters, coils, and stents, and clot retrieval has turned strokes into treatable emergencies. The speakers emphasize that stroke care now resembles heart attack care, with rapid, catheter-based interventions redefining outcomes and shortening hospital stays. GBMs emerge as particularly lethal because of their heterogeneity and diffuse invasion beyond visible margins. The conversation notes that modern centers now perform genetic profiling of tumors, guiding targeted chemotherapy and immunotherapy as we learn to unleash the immune system while preserving normal brain tissue. The blood-brain barrier remains a barrier, but focused ultrasound and related approaches are opening it to deliver molecular therapies. Surgery still extends survival by enabling more complete resection, but the goal is to combine biology, imaging, and immune strategies to create personalized, durable control. Brain-computer interfaces become central as a practical therapy, illustrated by the Bravo trial and Ann’s case. An array of 253 ECOG sensors placed on the speech-related cortex captured a patient’s intention to speak and translated neural signals into text, achieving initial accuracy around 50% and reaching near-perfect decoding within a week. New work demonstrates streaming decoding with sub-second latency. The approach combines neural decoding with language models to generate fluent speech, and plans toward fully implantable, wireless devices. The discussion also envisions regenerative and biotech advances, including stem cell strategies, while acknowledging ethical questions.

The Tim Ferriss Show

The New Frontiers of Mental Health — Brain Stimulation, Rapid-Acting Tools for Depression, and More
reSee.it Podcast Summary
Deardra Leeman, a woman in her 50s or 60s from the Bay Area, suffered from bipolar disorder and experienced a severe depressive episode that led to suicidal ideation. Her psychiatrist, having attended a talk by Dr. Williams on rapid-acting neurostimulation, reached out for help. Dr. Williams assessed her condition and recommended inpatient treatment due to the severity of her symptoms. Upon admission, Deardra was in a catatonic state, unable to communicate and exhibiting severe depression. Dr. Williams instructed her family to ensure her safety until treatment could begin. On the following Monday, Deardra underwent accelerated transcranial magnetic stimulation (TMS) therapy. Despite initial equipment issues, she was treated successfully with a second machine. Remarkably, within 24 hours, Deardra showed no signs of depression or suicidality, appearing completely normal. This rapid response is particularly notable in bipolar patients, where treatment can be effective in as little as a day. The average time for major depression patients to respond is around 2.6 days. Following her treatment, Deardra and her family became advocates for the therapy, helping to fund further research and trials. Deardra remained asymptomatic for about a year, requiring occasional "touch-ups" to maintain her mental health. Dr. Williams emphasized the potential of accelerated TMS to quickly alleviate severe depressive symptoms, particularly in treatment-resistant cases. The conversation then shifted to the underlying mechanisms of brain activity in depression. Dr. Williams discussed a study on resting state functional connectivity MRI, which examines how different brain regions activate in relation to each other. He explained that in healthy individuals, certain areas of the brain activate in a coordinated manner, while in depressed individuals, this timing can be disrupted, leading to a different pattern of brain activity. This disruption may serve as a biomarker for identifying patients who would respond to rapid-acting neurostimulation. Dr. Williams outlined the evolution of psychiatric treatment paradigms, moving from a focus on life experiences (Psychiatry 1.0) to chemical imbalances (Psychiatry 2.0), and now to a circuit-based understanding of mental health (Psychiatry 3.0). He argued that understanding mental health as a circuit problem rather than a chemical one empowers patients, as it suggests that interventions can rewire the brain's circuitry without relying solely on medications. The discussion also touched on the potential of ibogaine, a psychedelic compound, for treating conditions like PTSD and addiction. Dr. Williams noted that ibogaine has shown promise in alleviating withdrawal symptoms in opioid addiction and may have broader applications in treating various psychiatric disorders. He highlighted the need for further research to understand ibogaine's mechanisms and its potential role in a new era of psychiatric treatment. Overall, the conversation emphasized the rapid advancements in neurostimulation therapies and the potential for new treatment paradigms that prioritize brain circuitry over traditional chemical imbalance theories. The ongoing research aims to refine these approaches, ultimately improving outcomes for patients with severe mental health conditions.

The Tim Ferriss Show

Dr. Michael Levin — Reprogramming Bioelectricity
Guests: Michael Levin
reSee.it Podcast Summary
Cancer is framed as an electrical dysregulation among cells, where cells lose cohesion and identity, and can be guided back toward a coordinated function by reestablishing electrical patterns rather than fixing DNA or destroying cells. In the conversation, the guest explains that bioelectricity comprises two main forms: neural activity in the brain and developmental bioelectricity guiding tissue formation, regeneration, and remodeling. Visualizing these patterns with voltage-sensitive dyes allows scientists to map and manipulate tissue-wide electrical memories, which can steer cells toward desired structures like eyes or limbs without changing genetic code. The discussion covers how memories are stored as bioelectric patterns, how altering patterns can produce durable changes (some lasting across the organism’s lifespan, others transient across generations), and how this framework challenges the DNA-centric view of biology. Regeneration, birth defects repair, and cancer suppression are highlighted as three primary human-relevant applications anticipated from this approach, with aging considered as another potential target for reinforcing correct pattern memory. The guest proposes that healing and aging problems may ultimately be addressed by improving the cellular collective’s goal-directedness and its ability to receive new, higher-level prompts, rather than by conventional gene therapy, stem cells, or scaffolds alone. The dialogue moves into the implications for humans: whether the same reprogrammability seen in flatworms and vertebrates exists in humans, and how it could interface with existing medical technologies, including existing vagus nerve stimulation approaches and cross-disciplinary innovations across biology, computer science, and engineering. The guest emphasizes that evolution has conserved these electrical pattern mechanisms, and that altering them could yield dramatic regenerative and anti-cancer outcomes, while acknowledging that translation to clinical practice will require careful, stepwise experimentation in mammals. The conversation also touches on aging theories, the nature of cognition across living and nonliving systems, and how education and research culture might evolve to recognize nontraditional forms of intelligence and problem-solving that emerge from complex, pattern-driven self-organization. The guest closes by recommending accessible reading and pointing listeners to online resources for further exploration of his lab work and ideas, encouraging cross-disciplinary dialogue and ongoing testing of these transformative concepts.

Huberman Lab

Dr. Casey Halpern: Biology & Treatments for Compulsive Eating & Behaviors | Huberman Lab Podcast #91
Guests: Casey Halpern
reSee.it Podcast Summary
In this episode of the Huberman Lab podcast, Andrew Huberman speaks with Dr. Casey Halpern, chief of neurosurgery at the University of Pennsylvania, focusing on innovative treatments for eating disorders and obsessive-compulsive behaviors through deep brain stimulation (DBS). Halpern's lab explores how engineered devices can directly stimulate brain circuits involved in compulsive behaviors, particularly in conditions like binge eating disorder and OCD. Halpern discusses a recent study published in *Nature Medicine* on responsive nucleus accumbens deep brain stimulation for loss of control eating. The nucleus accumbens plays a crucial role in dopamine release and motivated behaviors, and stimulating this area can help control compulsive eating, even when individuals are aware they shouldn't eat. This approach represents a significant advancement in neuroscience, aiming to modify brain circuits to treat debilitating conditions. The conversation also covers the use of DBS for movement disorders, such as Parkinson's disease and essential tremor, highlighting the immediate relief patients experience from tremors through targeted stimulation. Halpern emphasizes the importance of understanding the brain's circuitry to develop effective therapies for various disorders, including OCD and eating disorders. Halpern explains that OCD is characterized by obsessions and compulsions, often requiring a combination of pharmacological treatments and cognitive behavioral therapy. However, about 30% of patients do not respond to these treatments, leading to the exploration of surgical options like DBS. He notes that while SSRIs and tricyclics are first-line treatments, they do not work for everyone, and the need for more effective interventions is critical. The discussion touches on the complexities of binge eating disorder, which is often linked to obesity but can occur independently. Halpern describes how his lab is conducting trials to understand the neural mechanisms behind binge eating and how to modulate the nucleus accumbens to restore normal function. He emphasizes the importance of distinguishing between loss of control eating and binge eating, as the latter requires specific criteria to be met. Halpern also shares insights into the role of awareness in managing compulsive behaviors, suggesting that while increased awareness can help some patients, those with severe disorders may still struggle to control their impulses. He advocates for the development of non-invasive techniques, such as transcranial magnetic stimulation (TMS) and focused ultrasound, to explore brain function without the need for invasive procedures. The episode concludes with a discussion on the potential of artificial intelligence and machine learning to predict and manage impulsive behaviors, highlighting the need for scalable solutions to address the widespread issues of mental health disorders. Halpern expresses hope for future research that will bridge the gap between invasive and non-invasive treatments, ultimately improving outcomes for patients suffering from these conditions.

Lex Fridman Podcast

Elon Musk: Neuralink and the Future of Humanity | Lex Fridman Podcast #438
Guests: Elon Musk
reSee.it Podcast Summary
The conversation features Elon Musk and members of the Neuralink team, including DJ Seo, Matthew MacDougall, Bliss Chapman, and Noland Arbaugh, the first human to receive a Neuralink implant. They discuss the groundbreaking implications of Neuralink for enhancing human capabilities and addressing neurological disorders. Elon Musk expresses excitement about the successful implantation of Neuralink in humans, highlighting the potential for significant advancements in brain-computer interfaces (BCIs). He mentions the goal of increasing the number of electrodes and improving signal processing, with aspirations to achieve data rates of up to 10,000 bits per second in the future. Musk emphasizes the transformative potential of BCIs for communication, intellectual discourse, and human-AI symbiosis. Noland shares his personal journey after becoming paralyzed from the shoulders down due to a diving accident. He discusses the emotional challenges he faced, the support from family and friends, and his determination to regain independence. Noland describes the experience of using the Neuralink device, noting how he can control a cursor with his thoughts and the joy of discovering that he can visualize cursor movements without attempting to move his body. The team explains the technical aspects of the Neuralink implant, including the use of flexible threads with electrodes that can record neural signals. They discuss the surgical procedure, the role of the robotic system in inserting the threads, and the importance of minimizing trauma to the brain. The conversation touches on the iterative process of improving the device and the user experience based on feedback from Noland. Noland highlights the significance of the calibration process, where he practices moving a cursor on a screen to help the system learn his intentions. He mentions the importance of user experience design in making the technology intuitive and effective. The team discusses the challenges of decoding neural signals and the need for continuous updates to improve performance. The conversation also explores the future possibilities of Neuralink, including restoring vision for the blind and enhancing communication for individuals with speech impairments. Noland expresses hope for the technology's potential to help many people regain independence and improve their quality of life. Overall, the discussion emphasizes the collaborative effort between humans and technology, the importance of user feedback, and the exciting future of brain-computer interfaces in transforming lives.

Huberman Lab

How to Set & Achieve Goals | Huberman Lab Essentials
reSee.it Podcast Summary
The episode shows how goal setting and pursuit rely on brain circuits. The amygdala links to anxiety and avoidance, the basal ganglia govern go/no-go actions, and the cortex—especially the lateral prefrontal and orbitofrontal areas—supports planning, emotional integration, and judging progress toward goals. Dopamine remains the main neuromodulator that values goals, drives pursuit, and signals reward prediction error, rising with unexpected positives and fluctuating with anticipated outcomes. The host reduces goal-directed behavior to three steps: identify a concrete goal, assess progress, and take action, with neural circuits dividing duties between value assessment and action. Realism and incremental challenge boost the odds of ongoing pursuit, showing that moderate, achievable goals activate autonomic arousal and readiness without overload. The walkthrough ties these ideas to classic animal and human studies, illustrating how motivation wavers when dopamine is depleted and how reward prediction error guides milestones for steady progress. Perceptual tools amplify goal pursuit. Space perception—distinguishing peripersonal and extrapersonal space—biases inward versus outward focus, and shifting attention between realms modulates dopamine, epinephrine, blood pressure, and readiness for action. Space-time bridging guides through sequential stations—from interoception to distant horizons—to align time with milestones. This practice translates ambitions into concrete steps by linking visual attention to actionable goals, reinforcing planning pathways, and maintaining a dynamic, time-aware pursuit rather than fixating on end outcomes.

ColdFusion

New Tech Makes Paralyzed Man Walk Again
reSee.it Podcast Summary
A team of scientists has developed a spinal cord implant that allows paraplegics to walk again by stimulating muscle movement. In a clinical trial, three men regained movement after surgery. The technology uses electrical currents to activate dormant motor neurons, mimicking natural movement patterns. Future trials will focus on more recent injuries and include brain implants for additional functions.

The Peter Attia Drive Podcast

191 - Revolutionizing our understanding of mental illness with optogenetics
Guests: Karl Deisseroth
reSee.it Podcast Summary
In this episode of The Drive Podcast, host Peter Attia welcomes Karl Deisseroth, a prominent psychiatrist and neuroscientist. They reminisce about their time at Stanford and discuss their academic journeys, including Deisseroth's MD-PhD program and his early interest in the brain. Deisseroth reflects on his decision to pursue psychiatry after initially aiming for neurosurgery, driven by a desire to understand the brain at both cellular and human levels. Deisseroth shares insights into the challenges of balancing clinical training with research, particularly during his residency, where he managed to maintain a connection to his lab work. He emphasizes the importance of the MSTP program, which allowed him to explore both clinical and research paths simultaneously. The conversation shifts to Deisseroth's groundbreaking work in optogenetics, a technique that allows scientists to control neurons with light. He explains how this technology emerged from the understanding of channel rhodopsins, proteins that respond to light, and how it enables precise manipulation of specific cell types in the brain. This advancement has profound implications for understanding and treating mental illnesses. Deisseroth discusses the significance of his research in understanding psychiatric disorders, particularly depression and anxiety. He highlights how optogenetics has helped identify the neural circuits involved in these conditions, revealing that different aspects of anxiety and depression can be traced to distinct cell types. This specificity opens new avenues for targeted treatments. The discussion also touches on the evolutionary basis of mental illnesses, including the potential adaptive value of traits like mania and the complexities of depression. Deisseroth reflects on the role of trauma in amplifying mental health issues and the importance of understanding these conditions through both genetic and environmental lenses. Throughout the conversation, Deisseroth emphasizes the need for a deeper understanding of the brain's mechanisms to develop effective treatments for psychiatric disorders. He expresses optimism about the future of neuroscience and the potential for optogenetics to inform new therapeutic strategies. The episode concludes with a discussion of Deisseroth's book, "Projections," which explores the emotional and psychological dimensions of mental illness. Attia praises Deisseroth's writing style and the accessibility of his insights, encouraging listeners to engage with the material. They agree to continue their conversation in the future, highlighting the ongoing exploration of topics such as personality disorders and the therapeutic potential of psychedelics.

TED

A Brain Implant That Turns Your Thoughts Into Text | Tom Oxley | TED
Guests: Tom Oxley
reSee.it Podcast Summary
A few months ago, I allowed Philip O'Keefe, who has paralysis, to tweet using a brain implant. This technology can be life-changing for those with disabilities. Philip and Rodney, both with ALS, can now text through a brain-computer interface (BCI). Traditional BCIs require invasive surgery, but we developed a Stentrode, which uses blood vessels to connect to the brain. This breakthrough allows patients to regain communication and autonomy, restoring dignity to their lives. Future applications may extend to conditions like epilepsy and dementia.

Huberman Lab

Dr. Eddie Chang: The Science of Learning & Speaking Languages | Huberman Lab Podcast #95
Guests: Eddie Chang
reSee.it Podcast Summary
In this episode of the Huberman Lab podcast, Andrew Huberman speaks with Dr. Eddie Chang, chair of the neurosurgery department at UCSF, who specializes in movement disorders, speech disorders, and bioengineering. Dr. Chang's lab has made significant advancements in allowing individuals with locked-in syndrome to communicate using brain-computer interfaces. They discuss critical periods in brain development, particularly regarding language acquisition, and how the brain controls speech and movement. Dr. Chang explains that the brain has sensitive periods for learning languages, where exposure to sounds shapes auditory processing. He shares insights from his research on rodents, revealing that raising them in white noise delays the maturation of their auditory cortex, which could impact language development. The conversation touches on the implications of environmental sounds on human language learning and the potential effects of white noise on infants. The discussion then shifts to the distinction between speech and language, highlighting the roles of Broca's and Wernicke's areas in the brain. Dr. Chang emphasizes that speech involves the motor control of vocalization, while language encompasses understanding and meaning. He describes how brain mapping during awake surgeries allows neurosurgeons to identify critical areas for speech and language, revealing surprising findings about brain function. Dr. Chang also addresses the complexities of stuttering, noting that it is a speech condition rather than a language issue, and discusses the potential for therapy to help individuals manage their stutter. He emphasizes the importance of auditory feedback in speech production and how disruptions in this feedback can contribute to stuttering. The conversation explores the future of brain-machine interfaces, particularly in enhancing communication for individuals with paralysis. Dr. Chang shares the story of Pancho, a patient who, after years of being locked in, was able to communicate using a brain-computer interface that translates brain activity into speech. This breakthrough highlights the potential for technology to restore communication and improve quality of life for those with severe disabilities. Finally, Dr. Chang discusses the ethical considerations surrounding brain augmentation technologies, such as those being developed by Neuralink, and the implications for society. He emphasizes the need for careful thought about the accessibility and impact of such technologies on human communication and cognition. Overall, the episode provides a deep dive into the neuroscience of speech and language, the potential for technological advancements to aid communication, and the ongoing exploration of the brain's capabilities.

Huberman Lab

How to Rewire Your Brain & Learn Faster | Dr. Michael Kilgard
Guests: Michael Kilgard
reSee.it Podcast Summary
Michael Kilgard explains that the adult brain can undergo massive plasticity when the right neuromodulatory signals are present. In his experiments, releasing acetylcholine, norepinephrine, serotonin, or dopamine in the adult brain can drive rewiring and learning that were once thought to be limited to development. Later work focuses on precise timing of neuromodulator release via vagus nerve stimulation, enabling targeted rewiring to treat conditions such as tinnitus, stroke, and spinal cord injury. Kilgard emphasizes that plasticity is not limited to ages under 25; development involves a long window during which experiences shape circuitry, but meaningful changes can occur across life with appropriate conditions. He notes that everyday experiences—bedtime storytelling, outdoor exploration, social interaction, and even choosing real-world activities over passive media—contribute to brain wiring, whereas constant passive stimulation may be less beneficial. He argues that the brain learns by a continual competition among trillions of connections, strengthening some while weakening others, with neuromodulators acting as crucial contextual signals that determine which synapses are solidified. On practical learning, Kilgard says focus and friction matter, and sleep and reflection consolidate changes. He discusses the importance of real experiences with natural statistics of the environment, and warns that superficial or artificial inputs (for example, endless videos) may not yield durable plastic changes. The conversation touches how the timing of neuromodulator release interacts with presynaptic activity to trigger spike-timing dependent plasticity and a synaptic eligibility trace, a four-factor learning rule that depends on precise timing and receptor activation. Clinical applications include vagus nerve stimulation paired with rehabilitation after stroke or spinal cord injury, where patients show meaningful gains within weeks. Kilgard describes a Lancet randomized trial showing hand function improvement after stroke with vagus nerve stimulation, and a Nature paper reporting restoration of motor function after spinal cord injury. He stresses that these strategies are adjuncts to therapy, not universal cures, and that progress comes from combining neuromodulation with targeted training, sensory and cognitive therapies, and careful patient selection. He also discusses tinnitus and how VNS aims to narrow auditory receptive fields by presenting tones that reshape neural maps; results are promising but not universal. The dialogue also covers the broader ecosystem of neuromodulation: psychedelics, SSRIs, nicotine, and other agents can amplify plasticity, but benefits depend on timing, context, and concurrent training. Kilgard argues for a multi-pronged approach—devices, pharmacology, and behavioral therapy—tailored to individual patients, with humility about limits and a long horizon for cures. The conversation ends with optimism about technology-assisted rehab, the social value of science, and the idea that plasticity endures across life but becomes more or less accessible depending on environment, sleep, and deliberate practice.

This Past Weekend

Dr. David Linden | This Past Weekend w/ Theo Von #595
Guests: David Linden
reSee.it Podcast Summary
David Lindon, a neuroscientist at Johns Hopkins, describes his work on brain injury recovery and translating basic science to patients. He explains that recovery is limited by axon regrowth in the adult brain and that therapies aim to promote regrowth. In mice, he says, researchers injure specific neurons using targeted approaches, including a lab stimulant called paracchloromphetamine, to reveal why certain serotonin neurons can regrow. These serotonin neurons, and some norepinephrine neurons, regrow, offering clues for therapies to help other neurons repair after injury. On depression, he notes that SSRIs do not damage serotonin neurons but have many side effects, such as reduced libido, and that efficacy is uneven: about a third respond well, a third modestly, a third not at all. He emphasizes that antidepressants are a temporary stopgap and that better therapies are needed. New single-cell analyses reveal fourteen flavors of serotonin neurons in the raphe, suggesting targets for more specific treatments. Moving to love and human nature, he points out that human parenting is unusually long and that paternity is accurately assigned in about 90–95% of cases worldwide. Long-term pairing supports offspring care, and mating behavior in humans is rare among mammals, contributing to the special status of love. He discusses attractiveness as fitness signals—symmetry, clear skin, height, and other cues that signal the ability to thrive and reproduce. On sexual orientation, he cites estimates that heritability is about 40% in men and 20% in women, notes that upbringing matters little for identity but influences willingness to express it, and quotes Pete Buttigieg: “If being gay was a choice, it was a choice that was made far far above my pay grade.” Beyond beauty, he notes that voices and smells matter, and discusses animal behavior across species, including sheep where homosexual behavior is observed but not exclusive. He explains that love at first sight engages dopamine in the ventral tegmental area while reducing prefrontal control and amygdala fear; long-term love often shifts to a calmer, more mature phase, with rare individuals maintaining intense feelings. In faith and science, he argues they are two branches of the same human pursuit, citing Vatican astronomy and science bodies, Buddhist openness, and the idea that science explains mysteries through falsifiable inquiry while faith offers meaning. He reflects on mortality, describing the brain as a prediction machine and explaining why humans fear nonexistence; he shares his own cancer journey—synovial sarcoma four years ago with a prognosis of six to eighteen months—and notes that love and his wife help sustain him biologically, with dopamine signaling potentially boosting immune response. His forthcoming book, The Real Science of Mind-Body Medicine, will investigate how thoughts, beliefs, and emotions can influence biology and disease progression; he cites the placebo effect as a biological phenomenon acting through mu opioid receptors. He surveys future biomedical advances with optimism: personalized medicine, gene editing (CRISPR), and AI-assisted data analysis, noting these could transform cancer treatment and neurological disorders. Finally, he warns that severe budget cuts to NIH and NSF could devastate research; the conversation turns to policy, funding, and the importance of sustaining science. Throughout, the themes converge: minds and bodies are linked; science and faith can coexist; love and purpose shape biology, health, and meaning.

Huberman Lab

Essentials: Compulsive Behaviors & Deep Brain Stimulation | Dr. Casey Halpern
Guests: Dr. Casey Halpern
reSee.it Podcast Summary
In this Essentials episode, Dr. Casey Halpern discusses how deep brain stimulation (DBS) targets network circuits in the brain to alleviate symptoms in movement and psychiatric disorders, with a focus on obsessive-compulsive tendencies and compulsive eating behaviors. He explains that DBS involves implanting thin, insulated wires into specific brain regions and delivering electrical stimulation through tiny contacts. While this can relieve tremor in Parkinson’s disease, the same approach can modulate limbic and cortical circuits involved in mood, anxiety, and compulsions. The conversation emphasizes that the brain’s reward and control systems are tightly linked, particularly through circuits that connect the prefrontal cortex with subcortical regions such as the basal ganglia and nucleus accumbens. When these circuits become hyperactive or dysregulated, individuals may experience persistent urges, cravings, or obsessive checking, despite risk. DBS can provide immediate symptom relief in select cases, offering a window into how precise neural modulation can transform functioning, mood, and behavior. The hosts explore current and emerging noninvasive alternatives, including TMS and focused ultrasound, and discuss the tradeoffs between reversible modulation versus ablation. They highlight the need for deeper, disease-specific targeting, the value of patient awareness and behavioral therapies, and the potential for future devices to anticipate and intervene before urges culminate in maladaptive actions. Throughout, the emphasis remains on careful patient selection, safety, and the ongoing quest to translate mechanistic insights into scalable, ethical treatments that address severe, treatment-resistant conditions.

Huberman Lab

Essentials: Understanding & Healing the Mind | Dr. Karl Deisseroth
Guests: Karl Deisseroth
reSee.it Podcast Summary
In this episode of Huberman Lab Essentials, Dr. Karl Deisseroth discusses the distinctions between neurology and psychiatry, emphasizing that psychiatry relies heavily on verbal communication due to the lack of measurable physical markers for mental disorders. He highlights the challenges of diagnosing patients who are less verbal, as well as the stigma surrounding psychiatric conditions that often prevents individuals from seeking help. Deisseroth believes that future advancements may lead to quantitative tests for conditions like depression and schizophrenia, although he acknowledges potential misuse. He also addresses effective treatments in psychiatry, including cognitive behavioral therapy for panic disorder and electroconvulsive therapy for treatment-resistant depression. The conversation touches on the potential of psychedelics and MDMA in treating mental health issues, noting their ability to alter perceptions and foster new connections in the brain. Deisseroth expresses optimism about the future of psychiatry, emphasizing the importance of understanding brain circuits and the potential for innovative treatments.

ColdFusion

Wheelchair-bound Man Walks Again After Stem Cell Injections!
reSee.it Podcast Summary
Researchers at Stanford University have achieved remarkable results in a clinical trial, where stroke patients regained motor functions after receiving stem cell injections into their brains. One patient, previously wheelchair-bound, could walk again. This breakthrough suggests potential for treating various neurodegenerative disorders.
View Full Interactive Feed